PH20494A - Use of prolactin secretion inhibitors in the prophylaxis of arteriosclerosis - Google Patents

Use of prolactin secretion inhibitors in the prophylaxis of arteriosclerosis

Info

Publication number
PH20494A
PH20494A PH26589A PH26589A PH20494A PH 20494 A PH20494 A PH 20494A PH 26589 A PH26589 A PH 26589A PH 26589 A PH26589 A PH 26589A PH 20494 A PH20494 A PH 20494A
Authority
PH
Philippines
Prior art keywords
arteriosclerosis
prophylaxis
secretion inhibitors
prolactin secretion
prolactin
Prior art date
Application number
PH26589A
Inventor
Brian Peter Richardson
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH20494A publication Critical patent/PH20494A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
PH26589A 1980-09-18 1981-12-07 Use of prolactin secretion inhibitors in the prophylaxis of arteriosclerosis PH20494A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8030228 1980-09-18

Publications (1)

Publication Number Publication Date
PH20494A true PH20494A (en) 1987-01-21

Family

ID=10516153

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26589A PH20494A (en) 1980-09-18 1981-12-07 Use of prolactin secretion inhibitors in the prophylaxis of arteriosclerosis

Country Status (5)

Country Link
JP (1) JPS5782317A (en)
AU (1) AU7544281A (en)
BE (1) BE890369A (en)
IT (1) IT1210577B (en)
PH (1) PH20494A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5565454A (en) * 1995-05-31 1996-10-15 Ergo Science, Incorporated Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders

Also Published As

Publication number Publication date
BE890369A (en) 1982-03-16
IT8149328A0 (en) 1981-09-18
IT1210577B (en) 1989-09-14
AU7544281A (en) 1982-03-25
JPS5782317A (en) 1982-05-22

Similar Documents

Publication Publication Date Title
DE3175201D1 (en) Aminothiadiazoles as gastric secretion inhibitors
GB2091858B (en) Surface treatment of objects
DE3176344D1 (en) Improvements in the replacement of mains
PT72914B (en) Beta-lactam compounds their preparation and use
ZA816242B (en) Use of pyridoxine alfa-ketoglutarate in the prophylaxis of hyperlacticacidaemia
GB8430707D0 (en) Restoration of timber components
PH20494A (en) Use of prolactin secretion inhibitors in the prophylaxis of arteriosclerosis
EP0048264A4 (en) Dental prophylaxis compositions and their use.
GB2074853B (en) Articles of furniture
PH15001A (en) Prolactin secretion inhibitors
GB2088422B (en) Surface treatment of wood
GB2081603B (en) Surface dressing
GB8323805D0 (en) Article of furniture
DE3162049D1 (en) Method for the preparation of 2-halo-3-sulfonyl-acrylonitriles and their use
GB2075352B (en) Equipment for the delivery of slurry and refinement during delivery
AU554021B2 (en) Use of pyridoxine alfa-ketoglutarate in the prophylaxis of hyperlacticacidaemia
ZA816717B (en) Compositions and use
DE3276758D1 (en) Use of (co)polytetramethylene-adipamide articles
ZA812834B (en) Aminothiadiazoles as gastric secretion inhibitors
JPS5771851A (en) Manufacture of kiln furniture
JPS56163623A (en) Polisher
JPS5661313A (en) Prolactin inhibitor
DE3170987D1 (en) Dental prophylaxis compositions and their use
KR840000615Y1 (en) Cue
HU182252B (en) Composition for the regeneration and caring of surfaces